GADOLIN: PRIMARY RESULTS FROM A PHASE III STUDY OF OBINUTUZUMAB PLUS BENDAMUSTINE COMPARED WITH BENDAMUSTINE ALONE IN PATIENTS WITH RITUXIMAB-REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA

被引：0

作者：

Sehn, L. ^{[1
,2
]}

Chua, N. ^{[3
]}

Mayer, J. ^{[4
]}

Dueck, G. ^{[5
]}

Trneny, M. ^{[6
]}

Bouabdallah, K. ^{[7
]}

Fowler, N. ^{[8
]}

Delwail, V. ^{[9
]}

Press, O. ^{[10
]}

Salles, G. ^{[11
]}

Gribben, J. ^{[12
]}

Lennard, A. ^{[3
]}

Lugtenburg, P. ^{[13
]}

Franklin, N. ^{[14
]}

Wassner-Fritsch, E. ^{[15
]}

Fingerle-Rowson, G. ^{[15
]}

Cheson, B. ^{[16
]}

机构：

[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada

[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada

[3] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada

[4] Brno & Masaryk Univ, Univ Hosp, Brno, Czech Republic

[5] BC Canc Agcy, Kelowna, Kelowna, BC, Canada

[6] Charles Univ Prague, Gen Hosp, Prague, Czech Republic

[7] CHU Haut Leveque, Pessac, France

[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[9] Univ Hosp, INSERM, Poitiers, France

[10] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[11] Hosp Civils Lyon, Pierre Benite, France

[12] Queen Mary Univ London, Barts Canc Inst, London, England

[13] Erasmus MC Canc Inst, Rotterdam, Netherlands

[14] F Hoffmann La Roche Ltd, Welwyn Garden City, Herts, England

[15] F Hoffmann La Roche Ltd, Basel, Switzerland

[16] Georgetown Univ Hosp, Washington, DC 20007 USA

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

LB691

引用

页码：273 / 273

页数：1

共 50 条

[21] Efficacy of bendamustine in rituximab-refractory indolent B-cell non-Hodgkin lymphoma: review of a pivotal trial [J].

Ujjani, Chaitra ;

Cheson, Bruce .

FUTURE ONCOLOGY, 2011, 7 (01) :9-14

[22] Bendamustine for the Treatment of Chronic Lymphocytic Leukemia and Rituximab-Refractory, Indolent B-Cell Non-Hodgkin Lymphoma [J].

Dennie, Trevor W. ;

Kolesar, Jill M. .

CLINICAL THERAPEUTICS, 2009, 31 :2290-2311

[23] Interest of the obinutuzumab (GA101) in combination with chemotherapy in refractory indolent non-Hodgkin's lymphoma to rituximab: results of the Phase III Gadolin [J].

Philippe, Laure .

HEMATOLOGIE, 2016, 22 (05) :311-+

[24] Phase II results of bendamustine in combination with rituximab in relapsed indolent non-Hodgkin's lymphoma [J].

van der Jagt, Richard H. ;

Cohen, Philip ;

Cheson, Bruce D. ;

Tulpule, Anil ;

Herst, Jordan A. ;

Lemieux, Bernard ;

Schwartzberg, Lee S. ;

Robinson, K. Sue ;

Oliver, Jennifer W. ;

Williams, Michael E. .

ANNALS OF ONCOLOGY, 2006, 17 :200-200

[25] Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway [J].

Fredrik Salvesen Haukaas ;

Audun Ohna ;

Tania Krivasi .

Applied Health Economics and Health Policy, 2018, 16 :569-577

[26] Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma [J].

de Vos, Sven ;

Wagner-Johnston, Nina D. ;

Coutre, Steven E. ;

Flinn, Ian W. ;

Schreeder, Marshall T. ;

Fowler, Nathan H. ;

Sharman, Jeff P. ;

Boccia, Ralph V. ;

Barrientos, Jacqueline C. ;

Rai, Kanti R. ;

Boyd, Thomas E. ;

Furman, Richard R. ;

Kim, Yeonhee ;

Godfrey, Wayne R. ;

Leonard, John P. .

BLOOD ADVANCES, 2016, 1 (02) :122-131

[27] Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway [J].

Haukaas, Fredrik Salvesen ;

Ohna, Audun ;

Krivasi, Tania .

APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (04) :569-577

[28] The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma [J].

Friedberg, Jonathan W. ;

Vose, Julie M. ;

Kelly, Jennifer L. ;

Young, Faith ;

Bernstein, Steven H. ;

Peterson, Derick ;

Rich, Lynn ;

Blumel, Susan ;

Proia, Nicole K. ;

Liesveld, Jane ;

Fisher, Richard I. ;

Armitage, James O. ;

Grant, Steven ;

Leonard, John P. .

BLOOD, 2011, 117 (10) :2807-2812

[29] Pharmacokinetics of Bendamustine Hydrochloride in Chinese Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Refractory to Rituximab Treatment [J].

Han, Xiaohong ;

Li, Ning ;

Song, Yuan-Yuan ;

Hellriegel, Edward ;

Robertson, Philmore ;

Shi, Yuan-Kai .

BLOOD, 2016, 128 (22)

[30] Bendamustine in patients with rituximab-refractory indolent and transformed non-hodgkin's lymphoma: Results from a phase II multicenter, single-agent study (vol 26, pg 204, 2008) [J].

Friedberg .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) :1911-1911

← 1 2 3 4 5 →